Pancreatic Cancer Research

ResearcherMedical University of South CarolinaActive in the last 2 years

Mark P. Rubinstein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4748-0286; OpenAlex author ID A5046739998, A5137013776. Sources: ClinicalTrials.gov.

Their work

Papers
7
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 trial · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review. Co-author DOI 10.3389/fonc.2026.1901721↗
  2. Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic review. Co-author DOI 10.3389/fonc.2026.1955091↗
  3. Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2025.01.005↗
  4. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Co-author DOI 10.3389/fimmu.2024.1324093↗
  5. Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1274783↗
  6. Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy. Co-author DOI 10.4081/oncol.2019.430↗
  7. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. Co-author DOI 10.1186/s13045-017-0459-2↗

Trials 1

  1. The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer Principal investigator NCT04602026↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ernest Ramsay Camp · 4 shared papers, 2019–2025 · strength 0.74
  2. Harrison Kim · 2 shared papers, 2026 · strength 0.63
  3. Supriya Peshin · 2 shared papers, 2026 · strength 0.63
  4. Ehab Takrori · 2 shared papers, 2026 · strength 0.63
  5. Shafia Rahman · 2 shared papers, 2026 · strength 0.63
  6. Zachary Gao · 3 shared papers, 2023–2025 · strength 0.62
  7. Derek J. Erstad · 2 shared papers, 2023–2025 · strength 0.41
  8. George Van Buren · 2 shared papers, 2023–2025 · strength 0.41
  9. Shalini Makawita · 1 shared paper, 2024 · strength 0.21
  10. Chrystal M Paulos · 2 shared papers, 2017–2019 · strength 0.18
  11. Jacob S. Bowers · 1 shared paper, 2019 · strength 0.12
  12. David J. Cole · 1 shared paper, 2017 · strength 0.06
  13. Shikhar Mehrotra · 1 shared paper, 2017 · strength 0.06
  14. Carolyn D. Britten · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.